Initial experience with the Diabetes Prevention and Control Alliance indicates that large-scale prevention and disease control management programs make economic sense.
This study describes the patient characteristics and healthcare utilization of a chronic pain population within an integrated healthcare system in northern California.
Worldwide, more than half a million new cases of hepatocellular carcinoma (HCC) are diagnosed annually. The incidence of HCC in the United States is rising with an estimated 31,000 new cases in 2018. Disease prognosis remains poor, with a 5-year survival rate across all disease stages estimated between 10%-20%, and 3% for those diagnosed with distant disease. Although morbidity is significant, especially among patients with advanced-stage disease, limited information exists on the humanistic and economic burden of HCC.
This editorial discusses the cost implication of bariatric surgery and whether or not return on investment analysis should be used to make coverage decisions.
Diabetes itself affected working and wages more than control of blood sugar levels in a Mexican American population.
Value-based programs such as accountable care organizations appear to encourage the adoption and spread of care coordination activities by hospitals.
An examination of socioeconomic disparities in cervical cancer screening across ethnic groups in the United States using concentration indices and probit regression analyses.
This study analyzes the current coverage designs for hepatitis C virus drugs by Medicare Part D plans.
Steering patients who visit providers with above-median prices to their market’s median-priced provider would save 42%, 45%, and 15% of laboratory, imaging, and durable medical equipment spending, respectively.
New ratings for Medicare health plans should spur a renewed focus on patient experience.
The Hospital-in-Home program implemented at the Veterans Affairs Pacific Islands Health Care System in Honolulu, Hawaii, is associated with reduced costs with no compromise in quality.
One-year persistence among new users of statins in Finland improved from 1995 to 1998, after which no substantial changes were observed up to 2004.
Value-based insurance design copayment reductions sustained medication adherence 2 years into policy implementation and were most effective in patients with poor adherence before policy implementation.
Authors from The Brookings Institution update their recommendations by focusing on 3 concrete objectives to slow spending and improve quality of care within the next 5 years.
Among nonelderly adults receiving hypertension treatment, 13.1% had high burdens, meaning that healthcare expenditures accounted for more than 20% of their income.
Higher intensity of care management in an all-condition program addressing care coordination and care barriers was associated with increased healthcare utilization among Medicaid and Medicare patients.